Cargando…
Codeine-containing medicines to be reclassified in NZ
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648239/ http://dx.doi.org/10.1007/s40278-020-85591-0 |
Ejemplares similares
-
NZ's Pharmac to fund baricitinib for moderate-to-severe COVID-19
Publicado: (2021) -
NZ's Pharmac negotiates deal for molnupiravir to treat COVID-19
Publicado: (2021) -
NZ's Pharmac to fund tocilizumab for moderate-to-severe cases of COVID-19
Publicado: (2021) -
NZ's Pharmac negotiates deal for Roche's monoclonal antibodies for COVID-19
Publicado: (2021) -
NZ's Medsafe reminder: pericarditis/myocarditis may occur after Comirnaty vaccination
Publicado: (2022)